Although in vitro studies demonstrated that expression of CBL exon 8 and/or exon 9 deletions in a CBL wild-type context shows a transforming phenotype, in the AML patients this alteration was found only in concomitance with other aberrations, particularly CBF leukemia [46]. The gene discussed is CBL; the disease is leukemia.